- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02736487
Effect of Short-term Portable Air Purifier Use on Occupant Health Indicators
April 7, 2016 updated by: Feng Li, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
The purpose of this research project is to examine whether short-term use of portable air pollution filtration can result in changes in indoor airborne pollutants and impact on cardiovascular and respiratory health outcomes of the inhabitants.
Study Overview
Status
Completed
Conditions
Detailed Description
This study will focus on evaluating the short-term benefits of a common portable air purifier technology in reducing air pollutant exposure and the anticipated concomitant health impacts.
High ambient levels of various air pollutants in the Shanghai area serve as a useful model to test the portable air purifier intervention in a realistic setting.
As most people using a portable air purifier would only be able to do so in their residences, the investigators have designed our study only to test residential air purifier use.
Our hypothesis is that the reduction in pollutant concentrations in indoor air caused by the air purifier will result in measurable reductions in risk factors for cardiovascular and respiratory diseases.
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 201620
- Shanghai First People's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy, non-smoking adults
- Live in the dormitory building at Shanghai First People's Hospital (South Section).
Exclusion Criteria:
- Current smokers
- Has any of the following diseases: chronic respiratory, cardiovascular, liver, renal, hematological disease; diabetes mellitus;
- Has any other diseases that may confound or complicate the effects of the intervention
- Pregnant females
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Group A: True-Washout-Sham
Subjects in group A receives true air filtration intervention, then at least two weeks of washout period, followed by sham air filtration intervention.
|
This intervention involved three sequential steps: (1) 12 to 20 hours of true air filtration intervention; (2) at least two weeks of washout period; (3) 12 to 20 hours of sham air filtration intervention.
In the indoor environment, the portable filtration device drew room air, sent it through filter and active carbon (for true filtration) or active carbon alone (sham filtration) and then delivered processed air back to room air.
In the study the portable filtration device processes 2.8 cubic meter of room air per minute.
The washout period lasted for at least two weeks where no filtration intervention was implemented.
|
ACTIVE_COMPARATOR: Group B: Sham-Washout-True
Subjects in group B receives sham air filtration intervention, then at least two weeks of washout period, followed by true air filtration intervention.
|
This intervention involved three sequential steps: (1) 12 to 20 hours of sham air filtration intervention; (2) at least two weeks of washout period; (3) 12 to 20 hours of true air filtration intervention.
In the indoor environment, the portable filtration device drew room air, sent it through filter and active carbon (for true filtration) or active carbon alone (sham filtration) and then delivered processed air back to room air.
In the study the portable filtration device processes 2.8 cubic meter of room air per minute.
The washout period lasted for at least two weeks where no filtration intervention was implemented.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline FEV1 (forced expiratory volume in the first second of exhalation) within 2h after the filtration intervention
Time Frame: Within 2h after the filtration intervention
|
FEV1 (forced expiratory volume in the first second of exhalation, unit: liter) was measured by spirometry in all subjects within 2h after the filtration intervention to compare to FEV1 value of study subjects at baseline (i.e. at start of the study).
|
Within 2h after the filtration intervention
|
Change from baseline R5 (airway resistance measured at 5Hz) within 2h after the filtration intervention
Time Frame: Within 2h after the filtration intervention
|
R5 (airway resistance measured at 5Hz) was accessed by impulse oscillometry in all subjects within 2h after the filtration intervention to compare to the R5 value of study subjects at baseline (i.e.
before the start of intervention).
|
Within 2h after the filtration intervention
|
Change in baseline exhaled nitric oxide (eNO) within 2h after the filtration intervention
Time Frame: Within 2h after the filtration intervention
|
Exhaled nitric oxide (eNO) was measured in all subjects within 2h after the filtration intervention to compare to the exhaled nitric oxide measurement of study subjects at baseline (i.e.
before the start of intervention).
Exhaled breath is collected in air sampling bags, and the concentration of NO was quantified by Thermo Scientific model 42i (NO-NO2-NOx) analyzer.
|
Within 2h after the filtration intervention
|
Change in exhaled nitric oxide (eNO) at 6h after filtration intervention compared to baseline
Time Frame: 6h after filtration intervention
|
Exhaled nitric oxide (eNO) was measured in all subjects 6h after filtration intervention to compare to the exhaled nitric oxide measurement of study subjects at baseline (i.e.
before the start of intervention).
Exhaled breath is collected in air sampling bags, and the concentration of NO was quantified by Thermo Scientific model 42i (NO-NO2-NOx) analyzer.
|
6h after filtration intervention
|
Change from baseline PWV (pulse wave velocity) within 2h after the filtration intervention
Time Frame: Within 2h after the filtration intervention
|
PWV (pulse wave velocity) was measured by the VICORDER instrument in all subjects right after filtration intervention to compare to the PWV value measured at baseline (i.e.
before the start of intervention).
|
Within 2h after the filtration intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline urinary biomarkers of inflammation and oxidative stress at 0h after the filtration intervention
Time Frame: At 0h after the filtration intervention
|
Urine samples were collected from each subject at 0h after the filtration intervention to quantify changes in urinary oxidative stress and inflammation biomarkers compared to baseline (i.e.
before intervention).
The urinary biomarkers to be analyzed include: malondialdehyde (MDA), 8-hydroxy-2' -deoxyguanosine (8-OHdG) and creatinine.
The unit of the urinary biomarkers will be reported as micro molar/ milliliter.
|
At 0h after the filtration intervention
|
Change in baseline urinary biomarkers of inflammation and oxidative stress at 6h after filtration intervention
Time Frame: 6h after filtration intervention
|
Urine samples were collected from each subject at 6h after filtration intervention to quantify changes in urinary oxidative stress and inflammation biomarkers compared to baseline (i.e.
before intervention).
The urinary biomarkers to be analyzed include: malondialdehyde (MDA), 8-hydroxy-2' -deoxyguanosine (8-OHdG) and creatinine.
The unit of the urinary biomarkers will be reported as micro molar/ milliliter.
|
6h after filtration intervention
|
Change in baseline urinary biomarkers of inflammation and oxidative stress at 24h after filtration intervention
Time Frame: 24h after filtration intervention
|
Urine samples were collected from each subject at 24h after filtration intervention to quantify changes in urinary oxidative stress and inflammation biomarkers compared to baseline (i.e.
before intervention).
The urinary biomarkers to be analyzed include: malondialdehyde (MDA), 8-hydroxy-2' -deoxyguanosine (8-OHdG) and creatinine.
The unit of the urinary biomarkers will be reported as micro molar/ milliliter.
|
24h after filtration intervention
|
Changes in baseline blood biomarkers of inflammation, oxidative stress and coagulation within 1h after filtration intervention
Time Frame: Within 1h after filtration intervention
|
Blood samples were collected within 1h after filtration intervention for comparison of inflammatory and oxidative stress biomarkers to their baseline level (i.e.
before the start of filtration intervention).
Blood biomarkers that will be analyzed include: P-selectin, c-reactive protein, Von Willebrand factor and fibrinogen.
The unit of the blood biomarkers will be reported as micro molar/ milliliter.
|
Within 1h after filtration intervention
|
Changes in baseline blood biomarkers of inflammation, oxidative stress and coagulation right after filtration intervention
Time Frame: 24h after filtration intervention
|
Blood samples were collected 24h after filtration intervention for comparison of inflammatory and oxidative stress biomarkers to their baseline level (i.e.
before the start of filtration intervention).
Blood biomarkers that will be analyzed include: P-selectin, c-reactive protein, Von Willebrand factor and fibrinogen.
The unit of the blood biomarkers will be reported as micro molar/ milliliter.
|
24h after filtration intervention
|
Change in the duration of deep sleep on the first night and the second night of study participation
Time Frame: On the first night and the second night of study participation
|
Duration of deep sleep was monitored by a sensor in a wristband on the first night and the second night of study participation
|
On the first night and the second night of study participation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2015
Primary Completion (ACTUAL)
December 1, 2015
Study Completion (ACTUAL)
December 1, 2015
Study Registration Dates
First Submitted
December 10, 2015
First Submitted That Met QC Criteria
April 7, 2016
First Posted (ESTIMATE)
April 13, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
April 13, 2016
Last Update Submitted That Met QC Criteria
April 7, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2015[38]
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-smoking, Healthy Adults
-
PfizerCompletedHealthy | Non-SmokingUnited States
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
Samsung Medical CenterTerminatedHealthy Aging | Healthy AdultsKorea, Republic of
-
Lumos Labs, Inc.Not yet recruitingHealthy AdultsUnited States
-
Shirley Ryan AbilityLabNot yet recruiting
-
National Institute of Allergy and Infectious Diseases...RecruitingHealthy AdultsUnited States
-
Arizona State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingHealthy AdultsUnited States
-
Marian NeuhouserDuke University; University of Washington; University of Nebraska; United States...Recruiting
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
Ohio State UniversityActive, not recruitingHealthy AdultsUnited States
Clinical Trials on True-Washout-Sham Air Filtration Intervention
-
UConn HealthBoston University; Tufts University; National Institute of Environmental Health... and other collaboratorsRecruitingBlood Pressure | Cardiovascular Risk FactorUnited States
-
Michigan State UniversityUniversity of MichiganCompletedCardiovascular Diseases in Old Age
-
University of MichiganNational Institute of Nursing Research (NINR); Michigan State UniversityRecruitingCardiometabolic HealthUnited States
-
University of MontanaNational Institute of Environmental Health Sciences (NIEHS)CompletedLower Tract Respiratory InfectionUnited States
-
Environmental Protection Agency (EPA)University of North Carolina, Chapel HillActive, not recruitingCardiovascular Diseases | Respiratory Tract DiseasesUnited States
-
University of MontanaNational Institute of Environmental Health Sciences (NIEHS)CompletedRespiratory Infection Other | Respiratory; Disorder, Functional, ImpairedUnited States
-
Hasselt UniversityRecruiting
-
Henry Ford Health SystemWayne State UniversityRecruiting